Cargo Therapeutics
PublicCargo Therapeutics is now publicly traded
The data on this page reflects Cargo Therapeutics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Nov 9, 2023
Last Round
M&A
Aug 19, 2025
Est. Valuation at Exit
$211.8M
Total Funding Raised
$846.05M
Company Overview
Cargo Therapeutics is a biotechnology company focused on developing next-generation, potentially curative cell therapies for cancer patients, utilizing innovative programs and manufacturing strategies to overcome the limitations of existing treatments.
Sector
Biotech
AI Layer
Non-AI
Keywords
Cargo Therapeutics Comparables
Compare Cargo Therapeutics with similar companies based on industry and business-model similarity.
No public comparables are available for Cargo Therapeutics. Request access to learn about comparables coverage.
Request accessCargo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Aug 19, 2025 | ||||
| Private Placement | May 28, 2024 | ||||
| IPO | Nov 9, 2023 | ||||
| Series A | Mar 1, 2023 | ||||
| Convertible Debt | Jan 1, 2023 | ||||
Seed | Jan 1, 2022 |
Cargo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EcoR1 Capital | Private Placement |
| Jefferies | IPO |
| Janus Henderson Group | Series A |
| Perceptive Advisors | Private Placement, Series A |
| Ally Bridge Group | Series A, Private Placement |
| Heartland Healthcare Capital | Series A |
| Xontogeny | Series A |
Cargo Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access